Puma Biotechnology Inc. (PBYI)
NASDAQ: PBYI
· Real-Time Price · USD
3.71
0.06 (1.64%)
At close: Jun 06, 2025, 3:59 PM
3.72
0.13%
After-hours: Jun 06, 2025, 04:04 PM EDT
Puma Biotechnology Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Product Revenue | 195.19M | 203.11M | 200.02M | 189.06M | 5.68M | 211.62M | 200.49M |
| Product Revenue Growth | -3.90% | +1.54% | +5.80% | +3227.42% | -97.31% | +5.55% | n/a |
| Royalty Revenue | 35.28M | 32.53M | 28.01M | 12.34M | n/a | 391K | n/a |
| Royalty Revenue Growth | +8.46% | +16.15% | +126.95% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 17.6M | 17.02M | 16.87M | 24.97M | 21.75M | 20.18M | 22.18M | 24.46M | 22.49M | 25.1M | 23.96M | 20.58M | 20.4M | 22.5M | 26.08M | 39.41M | 28.24M | 28.8M | 29.6M | 29.35M | 30.94M | 31.3M | 31.4M | 33.53M | 45.5M | 41M | 28.5M | 40.13M | 36.6M | 30.9M | 32.49M | 24.93M | 18.4M | 16.5M | 14.02M | 12.27M | 11.04M | 9.6M | 8.81M | 5.53M | 7.87M |
| Selling, General, and Administrative Revenue Growth | +3.43% | +0.91% | -32.46% | +14.81% | +7.76% | -8.98% | -9.35% | +8.79% | -10.41% | +4.75% | +16.45% | +0.85% | -9.32% | -13.74% | -33.81% | +39.56% | -1.95% | -2.70% | +0.86% | -5.14% | -1.16% | -0.32% | -6.34% | -26.31% | +10.98% | +43.86% | -28.99% | +9.65% | +18.45% | -4.89% | +30.33% | +35.48% | +11.52% | +17.67% | +14.33% | +11.11% | +14.99% | +8.98% | +59.24% | -29.72% | n/a |
| Research and Development Revenue | 13.86M | 15.17M | 12.55M | 13.63M | 13.59M | 12.87M | 11.45M | 13.36M | 12.71M | 13.8M | 11.25M | 11.97M | 15.24M | 14.2M | 18.84M | 18.64M | 20.23M | 24.2M | 23.34M | 24.69M | 25.45M | 30.2M | 30M | 36.85M | 35.7M | 38.4M | 36.4M | 43.24M | 46.92M | 50.2M | 49.5M | 53.25M | 54.8M | 56.4M | 51.98M | 54.22M | 60.21M | 52.5M | 51.92M | 59.38M | 44.73M |
| Research and Development Revenue Growth | -8.61% | +20.90% | -7.96% | +0.33% | +5.55% | +12.47% | -14.31% | +5.12% | -7.93% | +22.63% | -5.96% | -21.47% | +7.30% | -24.61% | +1.06% | -7.86% | -16.41% | +3.67% | -5.46% | -3.00% | -15.71% | +0.67% | -18.60% | +3.24% | -7.03% | +5.49% | -15.83% | -7.84% | -6.52% | +1.41% | -7.04% | -2.82% | -2.84% | +8.51% | -4.13% | -9.95% | +14.68% | +1.11% | -12.56% | +32.76% | n/a |